Rare Disease Pharmacy Solutions
Orsini is a leader in pharmacy solutions for rare disease and complex therapy programs. Rooted in specialty pharmacy, our solutions simplify how patients connect to therapies they need.
About Us
No Patient Left Behind
At Orsini, “No Patient Left Behind” isn’t just a catchphrase; it’s a commitment to ensuring that all patients receive the attention and care they deserve. Providing comprehensive and compassionate care since 1987, Orsini is a leader in supporting rare disease and cell and gene therapies.
Stories
Patient Stories
Testimonials
What Our Partners Say
“I have a patient that would have trouble navigating prescription issues and Orsini staff made it very easy for her.”
Orsini Prescriber
“The employees have always been helpful to me with whatever I need. They are kind and explain everything I need to know.”
Orsini Patient
“Orsini customer service has been extremely easy to work with, and has had great solutions for us when there are issues.”
Orsini Prescriber
“The experience has been next-level; it’s not something we’ve ever experienced with a specialty pharmacy. The advisors we talk to are always so helpful and kind and understanding.”
Orsini Caregiver
“The staff at Orsini works with professionalism, courtesy and proficiency all the time.”
Orsini Prescriber
“I feel they know you are a patient in need of the medication you are ordering from them, they treat you like a person not a number I’ve always been grateful for their service.”
Orsini Patient
“Always friendly, on time, knowledgeable and handle things professionally.”
Orsini Patient
“Orsini has excelled in numerous areas that include turnaround time from referral to dispense, insurance verification and authorization of therapy, coordination with the HUB, and timely feedback to our office staff. We are highly impressed with how smooth Orsini makes the process for both our staff and our patients.”
Neuromuscular Program Medical Director at a Leading Children’s Hospital
“Anything we need they send and it’s always there in time.”